ADHD treatment access a ‘postcode lottery’ As pressure mounts on existing services, the RACGP is calling for national equity in the treatment and management of people with ADHD.
GPs to diagnose and prescribe for ADHD under ‘breakthrough’ plan West Australian GPs could soon be allowed to diagnose, initiate and manage treatment with stimulant medications.
ADHD med shortages ‘a merry-go-round you just can’t predict’ The new school year has coincided with another series of shortages, forcing patients and prescribers to rethink their options.
RACGP calls for fast-tracked ADHD reform Ahead of a mass walk-out of NSW psychiatrists, the RACGP says it is now more important than ever for GPs to be granted ADHD prescribing powers.
Federal Government backs ADHD prescribing consistency In response to last year’s Senate Inquiry, it also supports-in-principle calls to review relevant MBS items and pathways to GP assessments.
RACGP fronts ADHD inquiry to fix system ‘serving no one’ An overhaul of Tasmania’s ADHD prescribing could be on the way, at a time when, the RACGP says, GPs are hamstrung by red tape and access barriers.
New ADHD prescribing guide launches The guide was designed to offer practical advice to GPs about safe and responsible prescribing, after finding significant variabilities.
ADHD med shortage set to end Supplies of lisdexamfetamine dimesilate should return to normal levels by the end of April, the TGA has advised.
The answer to psychiatric and child development waitlists Allowing trained GPs to initiate stimulant prescriptions for ADHD would help families and clinicians, writes Dr Andrew Leech.
Should ADHD medications be stopped during pregnancy? A new study found dexamphetamine does not put mothers or their babies at risk, but stopping before conception could be beneficial for some.